Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validating a point-of-care test for Toxoplasma gondii infection in southern sea otters (Enhydra lutris nereis).

Parasitology research·2026
Same author

Evaluating the feasibility of the CIPHER metadata framework towards building a conceptual phenotype standard.

JAMIA open·2026
Same author

Ten Years of Innovation: Transforming Research in Ageing Through the Melbourne Ageing Research Collaboration (MARC).

Australasian journal on ageing·2026
Same author

Short-Term Outcomes of Laparoscopic Hiatal Hernia Repair with Consecutive Transoral Incisionless Fundoplication: A Prospective Multicenter Cohort Study.

Journal of the American College of Surgeons·2026
Same author

Applying Lean Six Sigma to improve efficiency in outpatient iodine-131 therapy: reducing process time and material waste.

BMJ open quality·2026
Same author

Repurposing insulin for Alzheimer's disease treatment: intranasal delivery of a thermoresponsive nanocarrier-based insulin formulation to the brain.

Drug delivery and translational research·2026

Related Experiment Video

Updated: Jul 14, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
07:35

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

CYP-mediated clozapine interactions: how predictable are they?

Manoranjenni Chetty1, Michael Murray

  • 1Pharmacogenomics and Drug Development Group, Faculty of Pharmacy, University of Sydney, NSW 2006, Australia.

Current Drug Metabolism
|May 17, 2007
PubMed
Summary

Clozapine is a vital antipsychotic for treatment-resistant psychosis. Understanding its drug interactions, particularly those involving cytochrome P450 enzymes, is crucial for optimizing patient outcomes and predicting responses.

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Related Experiment Videos

Last Updated: Jul 14, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
07:35

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Area of Science:

  • Pharmacology
  • Psychiatry
  • Drug Metabolism

Background:

  • Clozapine is the most effective antipsychotic for treatment-resistant patients.
  • Therapeutic clozapine serum concentrations range from 350 to 1000 microg/L.
  • Pharmacokinetic interactions significantly impact clozapine response.

Purpose of the Study:

  • To review the pharmacokinetic interactions of clozapine.
  • To elucidate the role of cytochrome P450 enzymes in clozapine metabolism.
  • To highlight challenges in predicting clozapine interactions.

Main Methods:

  • Literature review of clozapine drug interactions.
  • Analysis of cytochrome P450 (CYP) enzyme involvement in clozapine metabolism.
  • Examination of interactions mediated by CYP1A2, CYP3A4, and other CYPs.

Main Results:

  • CYP1A2 is the primary enzyme in clozapine metabolism; CYP3A4, CYP2D6, CYP2C9, and CYP2C19 play minor roles.
  • Interactions with potent CYP1A2 inhibitors/inducers are predictable and clinically significant.
  • Interactions involving other CYPs or non-CYP pathways are less predictable and inconsistently reported.

Conclusions:

  • CYP1A2 plays a major role in clozapine metabolism, influencing predictable interactions.
  • Interactions with other cytochrome P450 enzymes or non-CYP pathways present challenges in prediction.
  • Further research into individual differences in clozapine metabolism is needed for improved interaction prediction.